As of 2025-08-06, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (9.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.21 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -331.0%.
The range of the Relative Valuation is (9.13) - (9.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 12.9x | 11.7x |
| Forward P/E multiples | 12.2x - 20.6x | 14.2x |
| Fair Price | (9.13) - (9.69) | (9.72) |
| Upside | -316.9% - -330.1% | -331.0% |
| Date | P/E |
| 2025-08-04 | -5.67 |
| 2025-08-01 | -5.58 |
| 2025-07-31 | -5.67 |
| 2025-07-30 | -6.22 |
| 2025-07-29 | -6.23 |
| 2025-07-28 | -6.26 |
| 2025-07-25 | -6.31 |
| 2025-07-24 | -6.38 |
| 2025-07-23 | -6.45 |
| 2025-07-22 | -6.27 |
| 2025-07-21 | -6.21 |
| 2025-07-18 | -6.37 |
| 2025-07-17 | -6.47 |
| 2025-07-16 | -6.41 |
| 2025-07-15 | -6.34 |
| 2025-07-14 | -6.62 |
| 2025-07-11 | -6.31 |
| 2025-07-10 | -6.65 |
| 2025-07-09 | -6.69 |
| 2025-07-08 | -6.47 |
| 2025-07-07 | -6.51 |
| 2025-07-03 | -6.62 |
| 2025-07-02 | -6.51 |
| 2025-07-01 | -6.23 |
| 2025-06-30 | -6.29 |
| 2025-06-27 | -6.37 |
| 2025-06-26 | -6.42 |
| 2025-06-25 | -6.14 |
| 2025-06-24 | -5.99 |
| 2025-06-23 | -5.95 |
| 2025-06-20 | -6.01 |
| 2025-06-18 | -6.03 |
| 2025-06-17 | -5.98 |
| 2025-06-16 | -6.10 |
| 2025-06-13 | -6.01 |
| 2025-06-12 | -6.17 |
| 2025-06-11 | -6.10 |
| 2025-06-10 | -6.21 |
| 2025-06-09 | -6.11 |
| 2025-06-06 | -6.14 |
| 2025-06-05 | -5.85 |
| 2025-06-04 | -5.91 |
| 2025-06-03 | -5.85 |
| 2025-06-02 | -5.73 |
| 2025-05-30 | -5.78 |
| 2025-05-29 | -5.85 |
| 2025-05-28 | -5.74 |
| 2025-05-27 | -5.77 |
| 2025-05-23 | -5.77 |
| 2025-05-22 | -5.65 |